Biogen Pharmachem Peer Comparison

BSE: 531752

₹0.26

₹0.00 (0.00%)

As on 06-Nov-2026IST

Market cap

₹27 Cr

Revenue (TTM)

₹1 Cr

P/E Ratio

47

P/B Ratio

0.2

Div. Yield

0 %

Edit

	Biogen Pharmachem	Mrugesh Trading	Mangal Credit	Gamco	Kartik Invst Trust
Market cap (₹ Cr)	27	5,136	503	248	194
Revenue (₹ Cr)	1	13	83	414	6
Net Profit (₹ Cr)	0.58	-0.02	19.07	-14.72	5.25
Net Margin (%)	31.53	-0.10	22.96	-3.55	83.79
RoE (%)	0.59	-0.02	10.86	-8.15	58.06
Price to Earnings	47.04	--	26.38	--	37.01
Price-To-Book	0.24	70.98	2.82	1.21	20.12

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Biogen Pharmachem	Mrugesh Trading	Mangal Credit	Gamco	Kartik Invst Trust
Operating Revenue	1.02	12.50	83.02	413.53	5.85
Total Income	1.85	14.33	83.05	414.41	6.26
Total Expenditure	1.26	14.16	16.44	404.85	0.10
EBITDA	-0.24	-1.66	66.57	8.68	5.75
Depreciation	0.00	0.00	1.94	0.86	0.00
EBIT	-0.24	-1.66	64.62	7.82	5.75
Interest	0.00	0.10	38.82	21.69	0.00
Other Income	0.83	1.84	0.04	0.88	0.41
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit before Tax	0.58	0.07	25.84	-12.99	6.16
Provision for Tax	0.00	0.09	6.77	1.73	0.92
Profit after Tax	0.58	-0.02	19.07	-14.72	5.25

Liabilities (₹ Cr)

	Biogen Pharmachem	Mrugesh Trading	Mangal Credit	Gamco	Kartik Invst Trust
Shareholder's Funds	99.57	72.36	178.51	205.91	9.65
Minority Interest	0.00	0.00	0.00	-0.02	0.00
Non-Current Liabilities	0.10	0.00	12.70	19.51	0.60
Current Liabilities	0.09	2.59	372.54	330.36	0.03
Total Liabilities	92.02	18.64	349.40	257.10	5.09

Assets (₹ Cr)

	Biogen Pharmachem	Mrugesh Trading	Mangal Credit	Gamco	Kartik Invst Trust
Non-Current Assets	98.00	0.00	14.68	96.10	8.85
Current Assets	1.76	74.94	544.87	225.76	1.42
Total Assets	92.02	18.64	349.40	257.10	5.09
Total Debt*	0.00	0.00	198.85	150.12	0.00
Net Current Assets	1.66	72.35	172.32	-104.60	1.39
Contingent Liabilities	--	--	0.99	1.07	--

Cashflow (₹ Cr)

	Biogen Pharmachem	Mrugesh Trading	Mangal Credit	Gamco	Kartik Invst Trust
Cash From Operating Activities	-1.08	-17.85	-49.36	-37.66	-0.06
Cash Flow from Investing Activities	-32.62	-0.01	-5.13	-13.22	0.08
Cash from Financing Activities	35.70	17.89	60.02	52.72	--
Net Cash Inflow / Outflow	2.00	0.03	5.52	1.84	0.02

Ratios

Profitability Ratios

	Biogen Pharmachem	Mrugesh Trading	Mangal Credit	Gamco	Kartik Invst Trust
ROCE (%)	-0.36	4.42	12.13	7.00	-0.60
ROE (%)	0.59	-0.02	10.86	-8.15	58.06
ROA (%)	0.59	-0.02	3.76	-3.30	66.25
EBIT Margin (%)	-23.80	-13.31	77.85	1.89	98.31
Net Margin (%)	31.53	-0.10	22.96	-3.55	83.79
Cash Profit Margin (%)	--	0.00	0.00	0.00	-111.21

Growth Ratios

	Biogen Pharmachem	Mrugesh Trading	Mangal Credit	Gamco	Kartik Invst Trust
Revenue Growth (%)	-64.73	21.04	47.35	187.18	25,339.13
EBIT Growth (%)	-115.24	-215.75	58.09	167.43	9,686.67
Net Profit Growth (%)	-66.12	95.99	57.77	9.74	21,954.17
EPS Growth (%)	-74.92	100.00	46.09	32.77	21,954.16
Book Value Growth (%)	-0.52	2,123.31	10.86	7.30	-6.11

Valuation Ratios

	Biogen Pharmachem	Mrugesh Trading	Mangal Credit	Gamco	Kartik Invst Trust
Price / Earnings	45.67	-3,43,429.95	26.38	-16.37	37.01
Price / Book Value	0.24	70.98	2.82	1.21	20.12
Dividend Yield (%)	0.00	0.00	0.31	0.00	0.00
EV/EBITDA	-104.37	-3,093.81	12.09	59.18	32.74
Market Cap (₹ Cr)	--	0.00	330.04	237.52	24.08

Solvency Ratios

	Biogen Pharmachem	Mrugesh Trading	Mangal Credit	Gamco	Kartik Invst Trust
Debt to Equity	0.00	0.00	0.00	0.00	0.00
Short term debt to equity ratio	--	--	0.95	1.51	--
Current Ratio	18.89	28.94	1.46	0.68	56.76
Quick Ratio	18.89	23.98	1.46	0.68	56.76
Interest Coverage	--	1.73	1.67	0.40	--

Operating Efficiency Ratios

	Biogen Pharmachem	Mrugesh Trading	Mangal Credit	Gamco	Kartik Invst Trust
Debtors to sales (%)	0.00	67.27	0.26	1.99	0.00
Asset Turnover	0.01	0.17	0.16	0.93	0.74
Receivable days	--	123.91	0.00	2.92	0.00
Inventory Days	--	206.23	0.00	310.12	0.00
Payable days	--	0.74	--	5.04	--
Cash Conversion Cycle	--	329.39	--	308.00	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly